Alert detail
LCD L36811: MolDX: Breast Cancer Assay: Prosigna® — WPS
What changed
Prosigna® breast cancer assay coverage now active in WPS J5/J8 regions.
Who’s affected: Oncology billing teams · Effective: May 1, 2025
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 6 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.